Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ari Schwartz (NPI 1336115666)

Field	Value
Entity Type	Individual
Organization	Ari Schwartz
Address	1351 Main St
City	Brockton
State	MA
ZIP	02301
Taxonomy	Rheumatology Physician
NPI Enumerated	February 27, 2006

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: reported total Medicare revenue is $1.7M and there is no Medicaid billing on file. The absence of Medicaid activity indicates the practice’s Medicare business drives its entire public‑payer footprint rather than a mixed payer mix.

Revenue is highly concentrated in three biologic infusion drugs: J1602 ($660K, 38.9%), J0129 ($430.1K, 25.3%), and J9312 ($327.6K, 19.3%). Those top three codes account for 83.5% of this provider's total Medicare revenue, indicating the practice’s financial performance is predominantly dependent on a narrow set of high‑cost injectable therapies.

The code mix and top revenue drivers point to an infusion‑focused rheumatology operation: high dollar biologic drugs (J1602, J0129, J9312), bone‑directed agents (J0897, J3489), and multiple infusion administration/chemotherapy codes (96413, 96401, 96415, 96365). Coupled with routine E/M codes (99214, 99213), the pattern is consistent with ongoing management and in‑office administration of biologic and parenteral therapies for chronic autoimmune or rheumatologic conditions.

For J1602 the provider is a high national volume outlier: 60K claims producing $660K revenue and ranking #27 of 1041 providers nationally (98th percentile; notably above typical national volume for this code). That combination of unusually large claim volume and outsized revenue share signals the provider is a major national participant for this specific infusion drug relative to peers.

Clinical/administrative activity beyond the drug lines is also elevated: 99214 reports 876 claims and $84.1K revenue, ranking #15797 of 479517 providers nationally (97th percentile; notably above typical national volume for this code), and 96413 reports 728 claims and $77.9K revenue, ranking #238 of 7514 providers nationally (97th percentile; notably above typical national volume for this code). These ranks indicate above‑typical throughput for both moderate complexity office visits and infusion administration compared with national peers.

Several infusion‑support codes show notable presence without driving large standalone revenue: J7050 has 1.5K claims with $0 revenue and ranks #25 of 1837 providers nationally (99th percentile; typical, unremarkable volume for this code), suggesting frequent use of saline infusions or saline billed alongside higher‑value drug administrations. Similarly, add‑on infusion time code 96415 (264 claims, $6.1K revenue) ranks #345 of 4959 (93th percentile; typical, unremarkable volume), corroborating regular multi‑hour infusion sessions.

Beyond the three dominant biologics, the rest of billed services are modest contributors: 99213 ($18.2K, 1.1%) and a range of joint injection and small procedure codes (20610, 20605, 20600) together represent only small fractions of Medicare revenue. This distribution reinforces that patient management and ancillary procedures are secondary to the practice’s infusion drug revenue stream.

The provider has long tenure in the Medicare program, with an NPI enumerated on 2006-02-27 (~20 years ago), indicating a stable, established practice presence. That longevity, combined with concentrated biologic administration and high national ranks on several infusion and visit codes, characterizes a mature infusion‑oriented rheumatology practice with limited or no Medicaid engagement.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1602	Injection, golimumab, 1 mg, for intravenous use	60,000	$10	$660K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	12,650	$30	$430.1K
J9312	Injection, rituximab, 10 mg	5,200	$60	$327.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	880	$100	$84.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	730	$110	$77.9K
J0897	Injection, denosumab, 1 mg	3,240	$20	$58.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	270	$70	$18.2K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	200	$60	$12K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	60	$130	$7.9K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	260	$20	$6.1K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Ari Schwartz — 3 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	3	20	6,600	$30	$256.2K
J9312	2	10	3,300	$60	$243.4K
J1602	1	10	11,100	$10	$160K
J0897	52	110	2,880	$20	$81.9K
96413	1	60	120	$110	$17.6K
99214	294	15,410	110	$80	$15.6K
96401	8	20	140	$60	$15.2K
99213	1,950	13,700	70	$60	$8.8K
20610	585	980	60	$50	$5.8K
99204	1,448	5,870	30	$120	$5.6K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ari Schwartz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Raphael Kieval	MA	Rheumatology Physician	$1.6M	$0
Kyu Kim	MA	Rheumatology Physician	$628.4K	$0

Nearby Providers

Other providers in the same ZIP code as Ari Schwartz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Commonwealth Of Massachusetts	MA	Case Management Agency	$0	$309.8M
Old Colony Elderly Services, Inc.	MA	Case Management Agency	$0	$137.5M
South Bay Mental Health Center, Inc.	MA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$112M
Massachusetts Mentor LLC	MA	Foster Care Agency	$0	$95.6M
Brockton Neighborhood Health Center	MA	Federally Qualified Health Center (FQHC)	$0	$91.2M
Sb Transitional Sub, LLC	MA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$84.8M
Steward Good Samaritan Medical Center, Inc.	MA	General Acute Care Hospital	$0	$64.2M
Pediatric Services Of America, LLC	MA	Nursing Care Agency	$0	$47.8M
South Bay Mental Health Center, Inc.	MA	Adolescent and Children Mental Health Clinic/Center	$0	$43.2M
Sb Transitional Sub, LLC	MA	Early Intervention Provider Agency	$0	$35.9M

Ari Schwartz — Billing Profile & Reimbursement Data

Sign up for Ari Schwartz — Billing Profile & Reimbursement Data policy alerts

Ari Schwartz — Billing Profile & Reimbursement Data

Sign up for Ari Schwartz — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References